Aldosterone Receptor Antagonists
- 23 February 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 121 (7) , 934-939
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunctionAmerican Heart Journal, 2009
- Aldosterone Antagonists for Preventing the Progression of Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2009
- Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronismExpert Opinion on Pharmacotherapy, 2008
- Selective Mineralocorticoid Receptor Blocker Eplerenone Reduces Resistance Artery Stiffness in Hypertensive PatientsHypertension, 2008
- Long-Term Cardiac Effects of Adrenalectomy or Mineralocorticoid Antagonists in Patients With Primary AldosteronismHypertension, 2007
- Effect of Spironolactone on Blood Pressure in Subjects With Resistant HypertensionHypertension, 2007
- Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activityNature Medicine, 2007
- The Adequacy of Laboratory Monitoring in Patients Treated With Spironolactone for Congestive Heart FailureJACC, 2005
- Primary Aldosteronism and Hypertensive DiseaseHypertension, 2003
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999